Medical artificial intelligence company Lunit (CEO Seo Beom-seok) announced on the 24th that it has begun direct sales in the Japanese market through Lunit Japan, a Japanese corporation established in May of last year.
Lunit has been entering the Japanese market through a partnership with Fujifilm, a global medical imaging equipment company and the leading company in the Japanese X-ray equipment and medical image archiving and transmission system market. Through this direct sales system, Lunit plans to provide localized marketing and solutions and enhance profitability.
Direct sales will operate in a complementary structure with Fujifilm's sales channels. In the hospital market, Lunit will maintain its existing partnership-based sales strategy, while in the screening and remote diagnosis markets, where demand for AI adoption is high, Lunit will directly identify customers and handle sales. The two companies plan to combine their competitive edge in the hospital channel with their AI expertise to expand the Japanese medical AI market.
Additional collaborations are continuing. This month, Fujifilm launched the latest version of CXR-AID, Lunit's AI-based chest X-ray interpretation software, in Japan. Since its initial launch in 2021, CXR-AID has been used in over 4,000 medical institutions in Japan. This version expands the number of detectable findings from three to ten.
Lunit is also expanding its collaboration with the Japanese government. On the 16th, it was invited as one of three global medical AI companies to the 2026 SaMD Forum, hosted by Japan's Ministry of Economy, Trade and Industry. The forum, which discussed the direction of industry-academia cooperation in the software medical device field, was attended by key figures from the Japanese medical device industry.
Lunit Japan plans to strengthen collaboration with Japanese partners and, based on insights gleaned from local customer encounters, expand globally proven solutions tailored to the Japanese market. Furthermore, the company envisions growth as a business hub for the Asia-Pacific region.
The company explained that Japan is a market with high demand for medical AI solutions due to factors such as an aging population, a shortage of medical personnel, and a high reliance on chest X-rays. Lunit Japan plans to focus on establishing a local business foundation this year and achieve full-scale sales growth through organizational expansion starting in 2027.
- See more related articles
You must be logged in to post a comment.